Cargando…

A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak

Antimicrobial stewardship is essential to reducing antimicrobial resistance, reducing costs, and, crucially, ensuring good patient care. Community-acquired pneumonia (CAP) is a common medical condition, the symptoms of which show a significant overlap with those of COVID-19. Following the COVID-19 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Howley, Fergal, Keating, Donal, Kelly, Mary, O’Connor, Roisin, O’Riordan, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559268/
https://www.ncbi.nlm.nih.gov/pubmed/36258797
http://dx.doi.org/10.1007/s42399-022-01311-0
_version_ 1784807617232633856
author Howley, Fergal
Keating, Donal
Kelly, Mary
O’Connor, Roisin
O’Riordan, Ruth
author_facet Howley, Fergal
Keating, Donal
Kelly, Mary
O’Connor, Roisin
O’Riordan, Ruth
author_sort Howley, Fergal
collection PubMed
description Antimicrobial stewardship is essential to reducing antimicrobial resistance, reducing costs, and, crucially, ensuring good patient care. Community-acquired pneumonia (CAP) is a common medical condition, the symptoms of which show a significant overlap with those of COVID-19. Following the COVID-19 outbreak in Ireland, patients presenting to our hospital with features of a respiratory infection were more commonly reviewed within 24 hours (24h) of admission by an infectious disease (ID) or respiratory specialist. We aimed to assess how the change in service provision, involving frequent specialist reviews of patients admitted with features of CAP during the first wave of the COVID-19 pandemic, affected antimicrobial stewardship and prescribing practices. Patients admitted under general medical teams treated for CAP from March–April 2020 were included. Retrospective data including demographics, CURB-65 score, and antimicrobial therapy were collected, as well as information on whether the patient had undergone specialist review by an ID or respiratory physician. Data were compared to a similar cohort treated for CAP between November 2019 and January 2020, though in this cohort, before the era of COVID-19, none of the patients had undergone specialist review. Seventy-six patients were included from the March–April 2020 cohort, with 77 from November 2019–January 2020 for comparison. An ID or respiratory specialist reviewed 35 patients from the March–April cohort within 24 h of admission. There was a higher rate of appropriate escalation, de-escalation, and continuation of antibiotics among those reviewed. Less than 20% of patients were started on antibiotics in accordance with CAP guidelines on admission, though the antibiotics initiated were frequently deemed appropriate in the clinical setting. Specialist review increases rates of appropriate antimicrobial prescribing and adherence with hospital guidelines in patients with CAP.
format Online
Article
Text
id pubmed-9559268
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-95592682022-10-14 A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak Howley, Fergal Keating, Donal Kelly, Mary O’Connor, Roisin O’Riordan, Ruth SN Compr Clin Med Original Paper Antimicrobial stewardship is essential to reducing antimicrobial resistance, reducing costs, and, crucially, ensuring good patient care. Community-acquired pneumonia (CAP) is a common medical condition, the symptoms of which show a significant overlap with those of COVID-19. Following the COVID-19 outbreak in Ireland, patients presenting to our hospital with features of a respiratory infection were more commonly reviewed within 24 hours (24h) of admission by an infectious disease (ID) or respiratory specialist. We aimed to assess how the change in service provision, involving frequent specialist reviews of patients admitted with features of CAP during the first wave of the COVID-19 pandemic, affected antimicrobial stewardship and prescribing practices. Patients admitted under general medical teams treated for CAP from March–April 2020 were included. Retrospective data including demographics, CURB-65 score, and antimicrobial therapy were collected, as well as information on whether the patient had undergone specialist review by an ID or respiratory physician. Data were compared to a similar cohort treated for CAP between November 2019 and January 2020, though in this cohort, before the era of COVID-19, none of the patients had undergone specialist review. Seventy-six patients were included from the March–April 2020 cohort, with 77 from November 2019–January 2020 for comparison. An ID or respiratory specialist reviewed 35 patients from the March–April cohort within 24 h of admission. There was a higher rate of appropriate escalation, de-escalation, and continuation of antibiotics among those reviewed. Less than 20% of patients were started on antibiotics in accordance with CAP guidelines on admission, though the antibiotics initiated were frequently deemed appropriate in the clinical setting. Specialist review increases rates of appropriate antimicrobial prescribing and adherence with hospital guidelines in patients with CAP. Springer International Publishing 2022-10-13 2022 /pmc/articles/PMC9559268/ /pubmed/36258797 http://dx.doi.org/10.1007/s42399-022-01311-0 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Howley, Fergal
Keating, Donal
Kelly, Mary
O’Connor, Roisin
O’Riordan, Ruth
A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title_full A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title_fullStr A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title_full_unstemmed A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title_short A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
title_sort service evaluation of adherence with antimicrobial guidelines in the treatment of community-acquired pneumonia before and during the sars-cov-2 outbreak
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559268/
https://www.ncbi.nlm.nih.gov/pubmed/36258797
http://dx.doi.org/10.1007/s42399-022-01311-0
work_keys_str_mv AT howleyfergal aserviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT keatingdonal aserviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT kellymary aserviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT oconnorroisin aserviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT oriordanruth aserviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT howleyfergal serviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT keatingdonal serviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT kellymary serviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT oconnorroisin serviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak
AT oriordanruth serviceevaluationofadherencewithantimicrobialguidelinesinthetreatmentofcommunityacquiredpneumoniabeforeandduringthesarscov2outbreak